A small but growing percentage of the funeral home industry — and the broader death care market — is being...
Read moreMedicaid, the government-funded U.S. health insurer for people with low incomes, grew by about 25% between February 2020 and May...
Read moreSelect over the counter hearing aids will be available soon. The move aims to lower costs. Instead, it will reveal...
Read moreAmazon acquired One Medical, a chain of concierge primary care clinics. The move expands Amazon's presence in virtual primary care....
Read moreMany point to rising drug costs as one cause of inflation. But drug costs do not affect consumer pricing, as...
Read morePolicy makers believe price transparency will help patients make cost-effective decisions. But patient decisions are made through trust, not cost-savings.
Read moreWe think disclosing the costs of clinical care will reduce overall costs. In reality, price transparency will increase the cost...
Read moreA report found most Medicare Advantage plans offer little value over traditional Medicare. We should now question the need for...
Read moreMost of the time when drugs are repurposed for diseases or conditions they were not originally intended for, it is...
Read moreIn between conspiracy and accounting resides the truth about the financial impact of COVID-19. As a systemic risk, it is...
Read moreGrowth is a curious thing. We know it when we see it, but we find it hard to replicate. This...
Read moreMedical debt in the United States has reached pandemic proportions. It is now the largest source of debt in the...
Read moreGlucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy